Cowen Investment Management, based in New York City, focuses on sustainable private equity and credit investments. The firm's portfolio spans various sectors, with a notable emphasis on healthcare and biotechnology companies. While specific investment sizes are not disclosed, their involvement in multiple post-IPO equity rounds suggests a preference for later-stage investments.

The firm's portfolio includes prominent companies such as Allogene Therapeutics, Blueprint Medicines, and Canopy Growth. Cowen Investment Management leverages its expertise in financial services to support portfolio companies, potentially offering strategic guidance and access to capital markets. Their investment approach appears to prioritize sustainable and innovative businesses across different industries.